Immune Effector Cellular Therapy Webinar: Bringing a Stand-Alone Immune Effector Cell Therapy Program into FACT Compliance
Register now:
Bringing a Stand-Alone Immune Effector Cell therapy Program into FACT Compliance
In This Issue
- Just the FACTs, 2020 Volume 5
- SAVE THE DATE: FACT Announces Virtual Inspection & Accreditation Workshop
- FACT Inspections Amid the Pandemic
- Please Complete Survey to Support Apheresis Cell Collection Standardization Efforts
- FACT Resources to Assist Your Program Throughout the Accreditation Process
- REMINDER: Public Comment Period Open for FACT Cellular Therapy Standards and Immune Effector Cell Standards
- Immune Effector Cellular Therapy Webinar: Bringing a Stand-Alone Immune Effector Cell Therapy Program into FACT Compliance
- Quality Management Series, Module 10: Validations
Accreditation Statistics
As of August 1, 2022
Cellular Therapy Entities
- Accredited: 250
- Applicants: 25
Cord Blood Banks
- Accredited: 56
- Applicants: 7
Congratulations to the following program for achieving initial FACT accreditation: King Abdulaziz Medical City - Riyadh, Saudi Arabia (adult and pediatric allogeneic and autologous hematopoietic progenitor cellular therapy; marrow and peripheral blood cellular therapy product collection; cellular therapy product processing with minimal manipulation). A complete list of accredited organizations can be found at www.factwebsite.org.
